COVID-19
COVID-19 presents important challenges for people affected by Scleroderma. This page puts together available resources and pertinent information for Scleroderma patients, as well as the initiatives to support the organization and patients during these difficult times.
Do you have questions about mental health, well-being, and coping in COVID-19? SPIN Director, Dr. Brett Thombs, and the SPIN Team are ready to provide answers. If you have questions, please submit them here https://bit.ly/2PlI0QI
More answers to your questions!
Immunosuppression is a risk factor, and having an interstitial lung disease (ILD) or Scleroderma without an ILD puts you at a slightly higher risk.
You have questions? Please view this videoforum captured on March 21 2020.
« Scleroderma & COVID-19 : A conversation with the experts »
Participants were invited to submit their questions concerning COVID-19 and Scleroderma in advance via an online Qualtrics questionnaire or to ask their questions directly to a team of five experienced panelists. Mrs. Maureen Sauvé, Dr. Janet Pope, Dr. John Varga, Dr. Don Sheppard and Dr. Brett Thombs. By typing them into the discussion section of GotoMeeting.
You can access a transcript of the questions and answers here!
More information
COVID-19 and Scleroderma – Information and recommandations
Make the difference!
Every donation and effort help us to make a difference to advance research and to support people affected by scleroderma in Manitoba.
Support research and scleroderma patients!
Columbia
